Protecting mitochondrial bioenergetic function during resuscitation from cardiac arrest

Crit Care Clin. 2012 Apr;28(2):245-70. doi: 10.1016/j.ccc.2012.02.001.

Abstract

Successful resuscitation from cardiac arrest requires reestablishment of aerobic metabolism by reperfusion with oxygenated blood of tissues that have been deprived of oxygen for variables periods of time. However, reperfusion concomitantly activates pathogenic mechanisms known as “reperfusion injury.” At the core of reperfusion injury are mitochondria, playing a critical role as effectors and targets of such injury. Mitochondrial injury compromises oxidative phosphorylation and also prompts release of cytochrome c to the cytosol and bloodstream where it correlates with severity of injury. Main drivers of such injury include Ca2+ overload and oxidative stress. Preclinical work shows that limiting myocardial cytosolic Na+ overload at the time of reperfusion attenuates mitochondrial Ca2+ overload and maintains oxidative phosphorylation yielding functional myocardial benefits that include preservation of left ventricular distensibility. Preservation of left ventricular distensibility enables hemodynamically more effective chest compression. Similar myocardial effect have been reported using erythropoietin hypothesized to protect mitochondrial bioenergetic function presumably through activation of pathways similar to those activated during preconditioning. Incorporation of novel and clinical relevant strategies to protect mitochondrial bioenergetic function are expected to attenuate injury at the time of reperfusion and enhance organ viability ultimately improving resuscitation and survival from cardiac arrest.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Cardiopulmonary Resuscitation / methods*
  • Energy Metabolism / physiology*
  • Erythropoietin / antagonists & inhibitors
  • Heart Arrest / physiopathology
  • Heart Arrest / therapy*
  • Humans
  • Mitochondria / physiology*
  • Mitochondria, Heart / physiology
  • Protein Isoforms / antagonists & inhibitors
  • Sodium-Hydrogen Exchangers / antagonists & inhibitors
  • Treatment Outcome

Substances

  • Protein Isoforms
  • Sodium-Hydrogen Exchangers
  • Erythropoietin
  • Adenosine Triphosphate